Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 30.29 USD -1.53% Market Closed
Market Cap: 1.7B USD

Intrinsic Value

The intrinsic value of one SUPN stock under the Base Case scenario is 43.8 USD. Compared to the current market price of 30.29 USD, Supernus Pharmaceuticals Inc is Undervalued by 31%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SUPN Intrinsic Value
43.8 USD
Undervaluation 31%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Supernus Pharmaceuticals Inc

SUPN
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for SUPN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Supernus Pharmaceuticals Inc
NASDAQ:SUPN
US
Pharmaceuticals
Market Cap
1.7B USD
IPO
Dec 28, 2010
US
Pharmaceuticals
Market Cap
1.7B USD
IPO
Dec 28, 2010
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SUPN?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Supernus Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Supernus Pharmaceuticals Inc

Current Assets 686.1m
Cash & Short-Term Investments 453.6m
Receivables 142.1m
Other Current Assets 90.4m
Non-Current Assets 682m
PP&E 36m
Intangibles 638.9m
Other Non-Current Assets 7.1m
Efficiency

Free Cash Flow Analysis
Supernus Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Supernus Pharmaceuticals Inc

Revenue
661.8m USD
Cost of Revenue
-69m USD
Gross Profit
592.8m USD
Operating Expenses
-502.2m USD
Operating Income
90.6m USD
Other Expenses
-16.7m USD
Net Income
73.9m USD
Fundamental Scores

SUPN Profitability Score
Profitability Due Diligence

Supernus Pharmaceuticals Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
53/100
Profitability
Score

Supernus Pharmaceuticals Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

SUPN Solvency Score
Solvency Due Diligence

Supernus Pharmaceuticals Inc's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
76/100
Solvency
Score

Supernus Pharmaceuticals Inc's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SUPN Price Targets Summary
Supernus Pharmaceuticals Inc

Wall Street analysts forecast SUPN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SUPN is 39.58 USD with a low forecast of 36.36 USD and a high forecast of 46.2 USD.

Lowest
Price Target
36.36 USD
20% Upside
Average
Price Target
39.58 USD
31% Upside
Highest
Price Target
46.2 USD
53% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Supernus Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SUPN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SUPN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one SUPN stock?

The intrinsic value of one SUPN stock under the Base Case scenario is 43.8 USD.

Is SUPN stock undervalued or overvalued?

Compared to the current market price of 30.29 USD, Supernus Pharmaceuticals Inc is Undervalued by 31%.

Back to Top